Caresyntax Hires Chief Strategy Officer to Drive Medtech Business Development13 Jul 2021
The company has also joined AdvaMed, the leading MedTech industry association
Boston (July TK, 2021) – Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, announced today that it has hired Rhonda Wallen as Chief Strategy Officer and Executive Vice President of Technology & Evidence Solutions to lead Caresyntax’s business development with medical device companies and develop new lines of business for other growing customer segments. Doubling down on its efforts to best serve medtech companies, Caresyntax also announced that it has joined AdvaMed, the world’s largest trade organization representing medical technology companies.
“Actionable insights from the operating room play an essential role in helping medical device companies optimize and improve their products,” said Dennis Kogan, Caresyntax founder and CEO. “With Rhonda driving our medtech efforts, Caresyntax is uniquely positioned to provide companies with the real-world evidence necessary to not only improve their products, but ultimately to deliver the best possible surgical outcomes and demonstrate value for health care providers and payors.”
Wallen brings over 25 years of diverse experience in the medical technology and health care industries. She previously served as the SVP of Marketing & Corporate Development at the SteriLumen division of Applied UV, which develops and acquires technologies for infection prevention and control. Prior to joining Applied UV, she served as the Head of Corporate Development for Terumo BCT, the blood and cellular technologies division of Terumo Corporation, a $5 billion multinational medical device company. She also served as Chief Operating Officer of Andarix, a clinical stage oncology therapeutics company, and President and CEO of Caveo Therapeutics, a biotechnology company with reagent and therapeutic antibody product lines.
At Caresyntax, Wallen will oversee growth of the company’s medical device and new business areas, including development and commercialization of clinical data-driven artificial intelligence and real-world evidence, as well as partnering and corporate development activities to support these efforts. She will also lead Caresyntax’s work with AdvaMed and its more than 400 members committed to advancing the medical device industry in order to achieve healthier lives around the world.
“Caresyntax has proven to be a trusted partner for over 1,000 hospitals, and I look forward to building on this solid foundation to bring the value of the Caresyntax platform to medical device companies,” Wallen said. “Medtech companies face increasing pressure to demonstrate their impact on lowering cost of care and improving patient outcomes. It is exciting to enable these companies’ continuous improvement with digital innovations, guided by real-world data.”
AdvaMed, the Advanced Medical Technology Association, advocates globally to bring patients access to life-saving medical technologies that meet the highest safety standards. AdvaMed’s Center for Digital Health promotes the critical role of data and digital medical technologies in improving patient care and advocates for public policies that advance digital health and the contributions of the medical technology industry to data-driven health care.
“Everything we do at Caresyntax is about making surgery smarter and safer,” Kogan said. “We’re proud to be part of an organization that supports our vision and shares our commitment.”
Caresyntax is on a mission to make surgery smarter and safer. Our enterprise-grade digital surgery platform delivers actionable insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical and operational data in and around the OR. This real world evidence can be used by the care team live, during a procedure and accessed by those outside the operating room via the platform’s dedicated telehealth link. After a procedure, the Caresyntax platform provides insights that help: surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. Headquartered in Boston, Caresyntax software is used in more than 4,000 operating rooms worldwide and supports surgical teams in over two million procedures per year. For more information, visit us at www.caresyntax.com.